-       Report 
   - August 2025
    -  181 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Report 
   - August 2025
    -  194 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €897EUR$1,000USD£788GBP 
      €1122EUR$1,250USD£984GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €897EUR$1,000USD£788GBP 
      €1122EUR$1,250USD£984GBP 
                  -       Report 
   - August 2025
    -  181 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                 -       Report 
   - November 2025
    -  376 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                  -       Report 
   - October 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - April 2025
    -  175 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - March 2025
    -  136 Pages 
    Global
   
   From       €4482EUR$4,995USD£3,934GBP 
                -       Drug Pipelines 
   - February 2020
    -  96 Pages 
    Global
   
   From       €3141EUR$3,500USD£2,756GBP 
                -       Report 
   - February 2024
    -  102 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                               
         Methyltransferase enzymes are a class of enzymes that catalyze the transfer of a methyl group from a donor molecule to an acceptor molecule. These enzymes are involved in a variety of biological processes, including DNA methylation, histone modification, and protein methylation. Methyltransferases are important for regulating gene expression, and they are also involved in the regulation of metabolic pathways.
The methyltransferase market is driven by the increasing demand for enzymes in the    pharmaceutical and biotechnology industries. The growing demand for enzymes in drug discovery and development, as well as in the production of biopharmaceuticals, is expected to drive the growth of the methyltransferase market. Additionally, the increasing demand for enzymes in food and beverage processing is expected to contribute to the growth of the market.
Some of the major companies in the methyltransferase market include Merck KGaA, Sigma-Aldrich, Novozymes, Roche, and Thermo Fisher Scientific. Show Less   Read more